For RCC, No Survival Benefit With Adjuvant Nivolumab
Physician's Weekly,
Results from the phase 3 Checkmate 914 trial demonstrate that adjuvant treatment with nivolumab/ipilimumab does not improve…
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Overview of attention for article published in Journal of Clinical Oncology, September 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
Good Attention Score compared to outputs of the same age and source (76th percentile)
Mentioned by
- news
- 7 news outlets
- blogs
- 2 blogs
- 68 X users
- guideline
- 3 clinical guideline sources
Readers on
- mendeley
- 215 Mendeley